Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
CRISPR Therapeutics Stock Quote

CRISPR Therapeutics (NASDAQ: CRSP)

Price as of May 23, 2024, 11:40 a.m. ET

CRISPR Therapeutics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CRSP -15.48% +53.51% +8.95% +303%
S&P +28.02% +87.79% +13.43% +147%

CRISPR Therapeutics Company Info

CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.

News & Analysis

The Fool has written over 400 articles on CRISPR Therapeutics.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.